Clinical Trial Update: A Window of Opportunity Study of Black Raspberry for Patients With HNSCC [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating black raspberry for patients with squamous cell carcinoma of the oral cavity or oropharynx has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• Black Raspberry

Snippet

Sponsor: Mitchell Machtay | Conditions: Squamous Cell Carcinoma of the Oral Cavity or Oropharynx | EARLY_Phase 1 | Status: WITHDRAWN